Clinical Trials Directory

Trials / Completed

CompletedNCT07419074

Hypoglycemic Potential of Garcinia Cambogia (Garcinia Gummi-gutta (L.) N.Robson) Rind Powder Among Pre-diebetic Obese Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
University of Lahore · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Accepted

Summary

Garcinia cambogia, rich in hydroxycitric acid (HCA), has been suggested to promote weight loss and improve metabolic parameters. Evidence regarding its efficacy in pre-diabetic obese adults remains limited. Objective: To evaluate the effects of Garcinia cambogia rind powder supplementation on anthropometric, glycemic, lipid, hepatic, and renal parameters in pre-diabetic obese adults.

Detailed description

The observed effects are likely mediated by HCA, which inhibits ATP-citrate lyase, reducing de novo lipogenesis, enhancing glucose utilization, and modulating adipokines and oxidative stress. Conclusion: Garcinia cambogia rind powder supplementation exerts dose-dependent metabolic benefits in pre-diabetic obese adults, improving anthropometric, glycemic, lipid, hepatic, and renal parameters without adverse effects. It may serve as a complementary intervention alongside lifestyle modification for the management of obesity and pre-diabetes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGarcinia cambogia rind powderOnce a day
DIETARY_SUPPLEMENTGarcinia cambogia rind powderOnce a day for 12 weeks

Timeline

Start date
2025-09-01
Primary completion
2025-11-24
Completion
2026-01-01
First posted
2026-02-18
Last updated
2026-02-18

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07419074. Inclusion in this directory is not an endorsement.